Lumos Pharma, Inc.

The current price of LUMO is 2.49 USD — it has increased by 1.63% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lumos Pharma, Inc. stocks are traded under the ticker LUMO.

Lumos Pharma, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Lumos Pharma, Inc. has a max estimate of 28.00 USD and a min estimate of 16.00 USD.

LUMO earnings for the last quarter are −1.04 USD whereas the estimation was −1.15 USD which accounts for 9.41% surprise. Estimated earnings for the next quarter are −1.14 USD. See more details about Lumos Pharma, Inc. earnings.

Yes, you can track Lumos Pharma, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, LUMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lumos Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.

LUMO reached its all-time high on Apr 9, 2015 with the price of 528.57 USD, and its all-time low was 2.41 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 33.00 employees. See our rating of the largest employees — is Lumos Pharma, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lumos Pharma, Inc. EBITDA is ‪−36.57 M‬ USD, and current EBITDA margin is ‪−1.78 K‬%. See more stats in Lumos Pharma, Inc. financial statements.